Sun Pharmaceutical Industries Ltd.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed a copy of the transcript of the Company’s Q2FY26 earnings conference call, which the company shall be uploading on its website after sending this letter.

The above information is a part of company’s filings submitted to BSE.